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The recombinant catalase-peroxidase HPI from E. coli was used as an alternative enzyme in polymerization reactions for the
production of (−) epicatechin oligomers and their biological activity was characterized. The enzyme was prepared in two forms: a
purified and an immobilized form. Both were tested for their activity in oxidative polymerization reactions, and their stability and
reusability were assessed. The polymerization reactions were followed by SEC-HPLC analyses, and the substrate was completely
converted into one or more polymerization products depending on the reactions conditions. Results showed that the utilized
conditions allowed for the isolation of some oligomers of different molecular weight: the oligomers containing 6 and 7 units of
epicatechin substrate are the heaviest ones. Epicatechin was also used in reactions catalyzed byHRP in the same reaction conditions
for comparison. In addition, one selected oligomer obtained byHPI enzyme catalysis was shown to act as in vitro inhibitor of tumor
cell growth, like one oligomer deriving from epicatechin by HRP catalysis. These data confirm that epicatechin oligomeric form
is more effective than its monomer in biological activity and suggest the use of HPI as an alternative enzyme in reactions for the
production of epicatechin oligomers.
1. Introduction
Phenol polymers are interesting compounds in various appli-
cations and their preparation has been pursued since many
years [1–4]. More recently, the possibility of having a green
alternative to classical catalysis has increased the amount
of enzymes utilized in this field. Two different enzyme
polymerization mechanisms emerged: the hydrolytic and the
oxidative mechanisms. Among oxidative catalysts a special
position is covered by plant and fungal enzymes, HRP (Horse
Radish Peroxidase), and laccases representing the most used
catalysts [5].
Peroxidases perform a broad range of radical-mediated
polymerization reactions [5–7].The reactions take advantage
of the ability of peroxidases to catalyze the formation of
free radicals that, in the appropriate conditions, undergo
spontaneous polymerization [8]. Enzymatic polymerization
of phenolic compounds performed by peroxidases mainly
from fungal and plant origin has been deeply studied [5, 9–
11].The advantages of phenolic compound polymerization by
these enzymes are as follows: the possibility of controlling
the polymer structure to modify its characteristics and its
solubility by changing the reactant ratio, solvents, and tem-
perature and the easy isolation and purification procedures
of the obtained compounds [7, 12–14].
Bacterial peroxidases are much less studied and used.
Nevertheless, they can represent another source of enzyme-
based catalysts. Among these, the catalase-peroxidase HPI
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from Escherichia coli [15, 16] is one of the most known mem-
bers of the class I catalase-peroxidase. These enzymes trans-
form the substances containing the peroxide bond, prefer-
entially hydrogen peroxide to oxygen and water [17–19]. In
addition to their catalase activities (with 𝑉max values in the
order of 2,000–6,000U/mg) [20], these enzymes function
as broad specificity peroxidases, oxidizing various electron
donors, including ABTS and o-dianisidine [5, 21, 22]. HPI
is an efficient peroxidase with an activity on o-dianisidine of
8.3U/mg at pH 4.25 [16, 20]. In a recent paper, its use as a
polymerization catalyst has been reported [16].
Polyphenols are an important subset of phenols. Most of
them are of natural origin and their functions are mainly
related to organism protection through their antioxidant
power [1–3, 23].The use of biocatalysis is considered a power-
ful alternative for their polymerization and HRP and laccases
have their intensive use [5, 6].However, in our knowledge this
is the first time that the use of bacterial peroxidases like HPI
protein for the polymerization of polyphenol compounds is
described. For this, the use of a very convenient and easy-to-
prepare bacterial peroxidase as HPI in order to make poly-
phenol polymers could add an important point to its exploita-
tion as a multifaceted catalyst.
Polyphenols have been used in veterinary and human
applications. These compounds are known for their broad
range of biological activity; they act as anticancer, anti-
inflammatory, antiallergic, and antiviral agents. In particular,
catechins are the most studied compounds also for their
ability to regulate the cycle in human cell lines [24–28].
It is also known that oligomers derived from polyphenols
are sometimes more effective than the corresponding mono-
mers; therefore, polyphenol polymerization has become a
matter of study.
Some preliminary data from Nagarajan et al. suggest that
epicatechin polymers obtained by HRP polymerization catal-
ysis could bemore effective than thecorrespondingmonomer
in tumor cell line growth inhibition [4]. It is thus straight-
forward to choose epicatechin as the substrate in our exper-
iments to test if the obtained products show a comparable
activity.
In this paper the results of polymerization reactions cata-
lyzed by HPI enzyme to obtain polymers of low molecular
weight from epicatechin are presented. In addition, it is
shown that the obtained oligomers can act, in vitro, as inhibi-
tors of tumor cell growth like oligomers derived from epicat-
echin by HRP peroxidase catalysis.
2. Materials and Methods
2.1. Crude Extract Preparation. E. coliM15[pREP4] (pQE30-
KATG) strain was grown at 37∘C in 500mL of LB medium
supplemented with ampicillin and kanamycin and 1mM
IPTG as reported by Di Gennaro et al. [16]. After 6 h from
induction at 30∘C, cells were harvested by 10min centrifuga-
tion at 6,000 rpm.
A pellet of cells equal to OD600 = 80 was resuspended
in 10mM phosphate buffer pH 7 and treated with 10mg/mL
of lysozyme for 30min at 4∘C. Then cells were disrupted by
sonication (five cycles of 10 s). The cell lysate was centrifuged
for 30min at 12,000 rpm at 4∘C, and the clear supernatant
(soluble fraction) was analysed by Bradford method as
reported in Di Gennaro et al. [16].
2.2. Enzyme Immobilization. Crude extracts (120mg) con-
taining the recombinant protein were added to 4mL of equi-
librated Co2+ affinity resin (Talon, Clontech) and incubated
for 20min at 4∘C. The resin was stored in the equilibration
buffer (Na3PO4 50mM, NaCl 300mM, pH 8) at 4
∘C.
2.3. His-HPI Protein Purification. TheHis-HPI protein puri-
fication was performed with the procedure described by Di
Gennaro et al. [16]. The protein concentration of eluted
aliquots was determined by Bradford method and a sample
of each of the eluted fractions was analysed by electrophoresis
on a 10% SDS-polyacrylamide gel (Novex Bis-Tris Gels 10%,
Invitrogen) and visualized with Comassie Brillant Blue to
verify the elution of protein [16]. Imidazole was removed by
a membrane dialysis tube with a 12,000-Da cut-off against
10mM phosphate buffer pH 7 overnight at 4∘C.
2.4. Peroxidase Activity Assay of HPI. To assess the perox-
idase activity of HPI in all its forms we used a standard
procedure. Protein sample (containing 0.02mg/mL of crude
extract or 0.0002mg/mL of purified protein) was added to a
solution containing 1.0mM pyrogallol in 10mM phosphate
buffer pH 7.0 and 0.88mMH2O2 [15]. Data were normalized
using as control a solution containing 1.0mM pyrogallol in
the appropriate phosphate buffer and 0.88mMH2O2 without
protein addition. All the reactionswere carried out at 30∘C for
4–10min, and all optical spectra were recorded with a Varian
Cary 3 UV-visible spectrophotometer. The molar extinction
coefficientwas 2640M−1 cm−1 at 430 nm.The specific activity
was determined as 𝜇mol ×mg−1 ×min−1.
2.5. Stability of the His-HPI in Different Conditions. All forms
of HPI (HPI immobilized to resin, HPI purified enzyme)
were tested for time stability measuring peroxidase activity
on pyrogallol. Different storage conditions of the 6x His-HPI
protein were used. In particular, different times of storage at
4 and −20∘C were used for each form.The activity was deter-
mined as reported above.
2.6. PolymerizationReactions. Polymerization reactionswere
carried out as reported byDiGennaro et al. [16].The reactions
were performed in a final volume of 2mL for test reactions
and 10mL for preparative reactions with 0.1mg/mL of puri-
fied HPI protein and 1mg/mL of substrate. Polymerization
reactions were performed also with HRP enzyme (Sigma-
Aldrich, 150–250U/mg, salt-free) in the same conditions uti-
lized withHPI.The reactions were initiated by the addition of
H2O2. When the substrate concentration remained constant
by HPLC analysis, the reactions were stopped and analysed.
The consumption of the substrate was monitored at
280 nm by HPLC-RP chromatography, using a reverse phase
LC-18 column with H2O/CH3CN 80 : 20 at 1mL/min flow.
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In order to perform the analysis of the polymerization
products theywere isolated. Depending on the reaction prod-
ucts we used a stepwise procedure. In presence of a solid pre-
cipitate the suspension was centrifuged (6000 rpm, at 4∘C),
the supernatant separated, and the solid washed twice with
water. The solid was then overnight dried in an oven at 70∘C.
The supernatant, as all the solutions directly coming from the
reactions, was acidified to pH 3 and extracted three times
using a mixture of butanol : ethyl acetate 1 : 9. The merged
organic phases were dried on Na2SO4 and filtered, and the
solvent evaporated at retention time using a gentle N2 flow.
2.7. Polymerization Product Characterizations
2.7.1. First Size-Exclusion Analysis (SEC-1). This system has
been used to determine the molecular weight (MW) of
some samples. The MW has been determined using a SEC
system based on aWaters 1515 Isocratic pump, 4 Phenomenex
columns (Phenogel 5 × 10−3 A˚-5 × 10−4 A˚-5 × 10−5 A˚-500 A˚
connected together), and an RI detector or an UV detector.
The analyses have been performed at r.t., at 1mL/min solvent
(THF) flow and 40 𝜇L of sample. Samples were prepared
dissolving 1mg of solid sample in 200𝜇L of THF (HPLC
grade). MWs are expressed in polystyrene (PS) equivalents.
Calibration has been realized using PS standards, with the fol-
lowing nominal peak molecular weight (MP) and molecular
weight distribution (𝐷) values: Mp = 1600000Da (𝐷 ≤ 1.13),
Mp = 1150000Da (𝐷 ≤ 1.09), Mp = 900000Da (𝐷 ≤ 1.06),
Mp = 400000Da (𝐷 ≤ 1.06), Mp = 200000Da (𝐷 ≤ 1.05),
Mp = 90000Da (𝐷 ≤ 1.04), Mp = 50400Da (𝐷 = 1.03), Mp
= 30000Da (𝐷 = 1.06), Mp = 17800Da (𝐷 = 1.03), Mp =
9730Da (𝐷 = 1.03), Mp = 5460Da (𝐷 = 1.03), Mp = 2032Da
(𝐷 = 1.06), Mp = 1241Da (𝐷 = 1.07), Mp = 906Da (𝐷 =
1.12), and Mp = 478Da (𝐷 = 1.22), with ethyl benzene (PM
= 106 g/mol). 1,2-Dichlorobenzene has been used as internal
standard.
2.7.2. Second Size-Exclusion Analysis (SEC-2). This system
has been used to calculate the MWs of the remaining
products. The MW has been determined using a SEC system
based on aWaters 600E pump, aWaters 486UVdetector, and
a Phenomenex column (Phenogel 5 𝜇, 100 A˚). The analyses
have been performed at r.t., at 0.3mL/min solvent (DMF)
flow and 20𝜇L of sample. Samples were prepared dissolving
1mg of solid in 1mL of DMF (HPLC grade). The MWs have
been calculated from a correlation line prepared using the
retention times and MWs of three standards: epicatechin,
oligomer at 1588mu, and oligomer at 2038mu. All measures
were repeated three times.
2.7.3. MALDI-TOF Analyses. MALDI-TOF analyses were
performed using the instrumentMALDI-TOFMICROFLEX,
Bruker Daltonics. DHB (gentisic acid) has been used as the
matrix. Samples were dissolved inMeOH. Two series of peaks
have been obtained: 2038-1750-1462-1174-886 and 1570-1282-
994-706.
2.8. Biological Activity Tests
2.8.1. Preparation of Cell Line Cultures. The human A375 and
WM 266-4 melanoma cell lines were maintained in DMEM,
supplemented with 10% fetal bovine serum (FBS), 2mM
L-glutamine, 100U/mL penicillin, and 100mg/mL strepto-
mycin (GE healthcare, Milan, Italy). Twice a week, cells
were detached with trypsin/EDTA (GE healthcare), counted,
and reseeded in a fresh culture medium at different densities.
2.8.2. Cell Proliferation Determination. Cell proliferation was
measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) assay [23]. A375 or WM 266-
4 cells were seeded (0.5 × 105 cells/well) in 24-well plates
and treated with increasing concentrations (0.01–10𝜇g/mL)
of each compound for 3 or 6 days at 37∘C in a 5% CO2
humidified incubator.The percentage of cell proliferationwas
calculated as [100(𝑥 − 𝑦)/(𝑧 − 𝑦)], where 𝑥, 𝑦, and 𝑧 were
the absorbance read in compound-treated, resting, and com-
pound-untreated cells, respectively.
2.8.3. Cell Cycle Analyses. The cell cycle was analysed by
measurement of the cellular DNA content using the fluores-
cent nucleic acid dye propidium iodide (PI) to identify the
proportion of cells that are in each stage of the cell cycle.
The assay was carried out using flow cytometry with a
fluorescence-activated cell sorter (FACS). A375 orWM266-4
cells were plated in p35 dish at a density of 5 × 105 cells/dish in
serum-freemedium.After 24 h of incubation at 37∘C, cultures
were changed to complete medium and 10 𝜇g/mL of each of
the compounds was added to the cells. After 3 or 6 days of
incubation, cells were trypsinized, pelleted by centrifugation
(400𝑔 for 5min), fixed by 70% ethanol, and stored at −20∘C
O/N. Fixed cells were stained in Tris-buffered saline (TBS)
containing 50 𝜇g/mL PI and 10𝜇g/mL RNase free of DNase.
They were incubated in the dark for 1 h at 4∘C. Cell cycle
analysis was performed by FACS (FACSVantage-SE flow
cytometer, BectonDickinson, Milan, Italy) at 488 nm.
2.8.4. Cell Viability. A375 or WM266-4 cells were labelled
with 1mM Calcein-AM (CAM) (Molecular Probes, Invitro-
gen) in serum-free PBS for 15min at 37∘C in the dark. After
being washed, labelled cells were seeded in 24-well plates and
allowed to adhere overnight at 37∘C in a humidified incu-
bator. Then, cells were treated with 10 𝜇g/mL of each of the
compounds for 6 days at 37∘C in a 5% CO2 humidified incu-
bator. After incubation the cells of each well were harvested,
washed, and labelled with propidium iodide (PI), and the via-
bility was measured by flow cytometry. Live cells were identi-
fied as CAMhigh/PI− population, apoptotic cells were CAM-
low, and late apoptotic/necrotic cells were CAMlow/PI+.The
percentage of live, apoptotic, and late apoptotic/necrotic cells
were calculated by FACSDiva software and expressed as the
percentage of CAMhigh/PI−, CAMlow, and CAMlow/PI+
population relative to untreated cells.
2.9. Statistical Analysis. Results were expressed as means ±
SEM of at least three experiments. Statistical significance was
evaluated by the one-wayANOVA followed by Student’s 𝑡-test
for paired populations, using GraphPad Prism 4 (GraphPad
Software, Inc., San Diego, CA, USA). Differences among
means were considered significant when 𝑝 ≤ 0.05.
4 BioMed Research International
HO
OH
OH
OH
OH
OH
OH
O
Figure 1: Dimerization of pyrogallol catalyzed by peroxidases.
3. Results
3.1. 6x His-HPI Preparation from E. coli M15[pREP4] (pQE30-
KATG) Crude Extract. To purify the 6x His-HPI recombi-
nant protein, the E. coli M15[pREP4] (pQE30-KATG) strain
was used. The crude extract was prepared and purified as
described in a previous paper by Di Gennaro et al. [16]. The
fractions were stored at −20∘C. To prepare the HPI enzyme
immobilized to resin, the enzyme loaded resin was stored in
the equilibration buffer; samples were stored at 4∘C and were
added to reaction solutions when needed.
3.2. HPI Peroxidase Activity. HPI activity is usuallymeasured
using o-dianisidine as the reference substrate [15]; however,
in our experience o-dianisidine cannot be used to measure
the activity of the immobilized HPI because it is irreversibly
adsorbed by the resin. In order to have a common substrate
to measure and compare enzyme activity in all its forms,
pyrogallol was selected as the reference substrate. Pyrogallol
can be oxidized to purpurogallin by peroxidases (Figure 1).
The HPI activity on pyrogallol was measured in the presence
of the enzymatic crude extract and in the presence of both the
enzyme immobilized on IMAC-Co2+ resin and the purified
enzyme. The crude extract showed an activity on pyrogallol
of 2.5 × 10−1 𝜇mol ×mg−1 ×min−1. The activity of the crude
extract when conserved at 4∘C significantly decreases after 28
days to 3.0 × 10−2 𝜇mol × mg−1 × min−1; in contrast, when
conserved at −20∘C it remains more or less constant over two
months. This permits the use of the extract without needing
a fresh preparation.
In order to have the biocatalyst in a form easy to
manage and recycle, the same resin used for its purification
(IMAC Co2+) was used for its immobilization. Although this
operation is fast and selective, it was necessary to test both
the enzyme activity and the stability of the enzyme in this
form. So, we performed preliminary activity tests on the
immobilized HPI form using pyrogallol as the reference sub-
strate in different experimental conditions. Initially, the
conditions used to perform the enzyme immobilization were
phosphate buffer 50mM at pH 8 with NaCl 1.8%; but at pH 8
pyrogallol spontaneously dimerizes and therefore a different
set of conditions was selected.The results showed that pH 6.5
and NaCl at 0.3% are the best conditions for the activity of
immobilized HPI on pyrogallol (4.5 × 10−1 𝜇mol × mg−1 ×
min−1); in these conditions the pure resin is inactive. Then,
activity retention tests of the enzyme in this form were per-
formed during the time. The enzyme immobilized onto the
resin (enzymatic resin hereafter) cannot be frozen because
the resin itself does notmaintain its characteristics.Therefore,
Table 1: Specific activity of HPI on resin on pyrogallol at 4∘C.a
Time Specific activity
1 d 2.0 ∗ 10−1 ± 2.2 ∗ 10−2
31 d 4.5 ∗ 10−1 ± 1.3 ∗ 10−1
41 d 5.4 ∗ 10−1 ± 5.6 ∗ 10−2
58 d 2.6 ∗ 10−1 ± 9.0 ∗ 10−2
121 d 3.2 ∗ 10−1 ± 4.7 ∗ 10−2
a𝜇molmin−1mg−1.
the tests were performed using enzymatic resin conserved at
4∘C in the equilibration buffer 50mM phosphate buffer at
pH 8 and with 1.8% NaCl; reactions were performed in the
reference conditions. Results showed that the enzyme pre-
serves its activity even after two months (Table 1; value varia-
tions are ascribed to the approximation in the resin amount
used in each experiment series).
The specific activity referred to pyrogallol oxidation of the
immobilized enzyme (0.45 𝜇mol × mg−1 × min−1) is nearly
twice as high as that of the enzyme in the crude extract
(0.23 𝜇mol × mg−1 × min−1). In a parallel series of tests the
activity and the activity retention of the purified enzymewere
checked. The specific activity of the purified HPI (0.17 𝜇mol
×mg−1 ×min−1) is 2.5 times lower than that of the enzymatic
resin. In addition, HPI activity is halved after one-month con
servation in the equilibration buffer both at 4∘C and at−20∘C.
This result showed that the immobilized HPI is much more
stable than the purified enzyme in similar conditions and that
it can be stored for more than 2 months at 4∘C without loss
of activity. Furthermore, the resin form can be easily used
several times showing similar efficiency (data not shown).
3.3. Epicatechin Polymerization Reactions. Catechins are the
principal structural units in condensed tannins. They belong
to the group of the 3-flavanols and are present in many
varieties of vegetables, herbs, and tees. They are active as
preventive of cancer and of inflammatory and cardiovascular
diseases, because of their antioxidant action that can limit and
remove free radicals [29]. It is also known that in the form of
oligomers their activity can be enhanced [4]. To this end, the
possibility of substituting the commonly used HRP (Horse
Radish Peroxidase) of vegetal origin with the microbial HPI
in polymerization reactions was investigated. The polymer-
ization of a catechin as the (−) epicatechin was initially
performed in different reaction conditions using HRP as ref-
erence. The reaction was followed by the consumption of the
substrate that was monitored by HPLC at 280 nm. In all the
tested conditions the amount of consumed (−) epicatechin
was over the 90% up to a concentration of 3.44mM in the
reaction.
Then, epicatechin polymerization was performed in the
same conditions utilized for HRP using the recombinant en-
zyme HPI (from E. coliM15(pREP4) (pQE30-katG)), immo-
bilized onto the IMAC resin. Also, in this case, the decrease
of the substrate was monitored by HPLC. The substrate
was always completely consumed, except when using a high
concentration of epicatechin (17.2mM) (Table 2). Finally,
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Table 2: Epicatechin consumed by immobilized HPI in different reaction conditions.
Reaction conditions H2O2 (mM) Enzyme (mg/mL) Consumed epicatechin
Epicatechin 3.44mM + EtOH 5% 15.5 0.00 No reaction
Epicatechin 0.69mM + EtOH 20% 11.2 0.01 >90%
Epicatechin 3.44mM + EtOH 5% 15.5 0.01 >90%
Epicatechin 3.44mM + EtOH 30% 8.8 0.01 >90%
Epicatechin 17.2mM + EtOH 30% 52.9 0.01 >25%
Table 3: Epicatechin consumed by purified HPI.
H2O2 additions Consumed epicatechin
0 [0.0mM] 0%
1 [3.9mM] 31%
2 [7.8mM] 31%
3 [11.7mM] 33%
4 [15.6mM] 48%
5 [19.5mM] 48%
6 [23.4mM] 50%
7 [27.3mM] 50%
8 [31.2mM] 57%
9 [35.1mM] 57%
experiments have been performed using the purified free
enzyme HPI. As it is shown in Table 3, the substrate was only
partially consumed (60%) even in the presence of a high con-
centration of protein (0.12mg/mL; i.e., 12 times the amount
present in the experiments with enzymatic resin). Results
indicated thatHPI can be considered a good biocatalyst in the
epicatechin polymerization only in the immobilized form.
3.4. Product Analysis and Characterization. To perform the
analysis of the polymerization products their preliminary
isolation was studied. The formed oligomers are differently
soluble in water and they partially precipitate. Because during
filtration the oligomers are easily adsorbed on the filters,
a procedure that contemplates two steps was used: first,
the separation of the solid by centrifugation and, second,
the extraction of the water phase with an organic mixture
(butanol : ethyl acetate). In addition, the solvent evaporation
should be made with care, to preserve the integrity of the
products.
The identification of the epicatechin oligomers produced
by the biocatalysts required the following procedure. One
product was characterized using Maldi mass analysis. Two
compounds were then analysed using a first SEC chromatog-
raphy system; this analysis confirmed Maldi result through
system calibration and gave a second product weight. Finally,
all the products were analysed using a second SEC chro-
matography system; using retention times of this analysis and
theMWs calculated using the previous analyses a correlation
line between retention times and molecular weights was
prepared.
Maldi mass analysis clearly shows two sets of peaks. The
first set has its highest MW at 2038 mass units, followed by
a regular series of peaks each separated by 288 mass units
OHO
OH
OH
OH
OH
109
181
Figure 2: Fragmentation of epicatechin.
(epicatechin monomer); the second set has its highest MW
at 1570 mass units, also followed by a regular series of peaks
each separated by 288mass units.The first series corresponds
to a 7-unit oligomer; the second series corresponds to a 6-
unit oligomer that lost a group weighting 180 units. This last
weight corresponds to the loss of the bicyclic part of epicat-
echin. At this analysis level it cannot be stated if the second
series derives from a self-standing oligomer or from the mass
analysis evolution.
In the first SEC analysis the compound MW was esti-
mated using a polystyrene (PS) based calibration; this permits
the calculation of an MW of 2326 for the compound used in
the Maldi analysis and of an MW of 1724 for a second com-
pound, selected for its well defined difference in chromatog-
raphy retention time. Using these two MWs and epicatechin
as reference, a correlation line between retention time and
MW was prepared using the second SEC system. Then, we
completed the analysis of the remaining compounds; the
results are reported in Table 4. The reaction conditions used
to prepare the analysed compounds are reported in Table 5.
Maldi and SEC analyses confirmed the presence of two
oligomers that lost the bicyclic part of epicatechin (Figure 2).
3.5. Effect of Epicatechin and of Oligomers from Epicatechin
by HPI and by HRP on Melanoma Cell Line Proliferation.
Since catechins have been demonstrated to inhibit tumor cell
line growth [2, 4, 30], the effect of epicatechin (EC) and one
of the oligomers from epicatechin by HPI (called polymer
A of 7 units of epicatechin) and one of the oligomers by
HRP (called polymer B of 7 units of epicatechin) was first
evaluated on melanoma cell line proliferation by MTT assay.
As shown in Figure 3 the treatment (6 days) of WM266-4
cell line with 10 𝜇g/mL of polymer A or polymer B resulted
in a slight but significant (𝑝 < 0.05) inhibition (−18% and
−15 for polymer A and polymer B, resp.) of cell proliferation.
Differently, the treatment (6 days) of A375 cell line induced
6 BioMed Research International
Table 4: MW of the obtained oligomers.
Compound Retention timea Measured MWb Calculated MWc Unitsd Enzyme
epicatechin 10.17 331e 1
P1 6.80 2326 2038 7 HRP
P2 7.33 1520 6f HPI
P3 7.32 1724 1529 6f HRP
P4 6.94 1885 7f HRP
P5 6.95 1875 7f HPI
P6 6.89 1937 7 HPI
aMeasuredusing SEC-2 system. bCalculatedusing SEC-1 system. cFrom the correlation line. dNumber of epicatechin units. eCorrectedweight usingMaldi/SEC
ratio. f From the compound that lost the bicyclic part.
Table 5: Conditions of reaction utilized for the obtained oligomers.
Compound Conc. EPI Enz. EtOH mLa
P1 3.44mM 1mg HRP 20% 20
P2b 3.44mM 0.01mg HPI 5% 1
P3 3.44mM 0.01mg HRP 5% 1
P4 3.44mM 0.01mg HRP 5% 20
P5 0.69mM 0.05mg HPI 20% 2.5
P6c 3.44mM 0.01mg HPI 5% 1
aReaction volume. b3mL of H2O2 added. c42mL of H2O2 added.
a significant (𝑝 < 0.05) concentration dependent reduction
of proliferation with a maximum of −28% and −21%, at
10 𝜇g/mL for polymer A and polymer B, respectively. In con-
trast, no effect was observed for EC on both cell lines at any
tested concentrations and times.
3.6. Effect of EC, Polymer A, and Polymer B on Melanoma
Cell Cycle. To further investigate the mechanism by which
polymer A and polymer B affect melanoma cell line prolifera-
tion, the cell cycle was analysed. A375 orWM266-4 cells were
treated with the compound and were shown to be active on
both cell lines in the proliferation assay (10 𝜇g/mL) for 6 days
and the distributions on cell cycle analysed by flow cytometry.
As shown by PI staining, exposure to polymer A and poly-
mer B (Figure 4) induced similar effects on both cell lines,
an increase in the cell number in the G0/G1 phases (+22%
and +17%, resp., for A375 cells; +25% and +20%, resp., for
WM266-4 cells) accompanied by a reduction of cell number
in S and G2 phases when compared with control cells,
indicating an arrest in G0/G1 phases in cell cycle progression.
Moreover a slight increase in debris was observed with both
polymer A and polymer B. EC treatment did not induce any
significant alteration in WM266-4 and A375 cells.
3.7. Effects of EC, Polymer A, and Polymer B on Cell Viability.
To evaluate whether tested compounds exert also cytotoxic
effects on tumor cells a CAM assay was performed. CAM
labelled A375 and WM26-4 were treated (6 days) with
10 𝜇g/mL of each compound, counterstained with PI and
analysed by FACS. As shown in Figure 5 both polymer A
and polymer B induced an increase in CAM negative cells
(apoptotic cells) (+26% and +20%, resp., for A375 cells; +15%
and +23%, resp., for WM266-4 cells), and a slight increase in
CAM−/PI+ cells (necrotic/late apoptotic cells). Conversely no
significant cell death was observed in cell treated with EC.
4. Discussion
The interest towards enzymatic polymerization reactions
catalyzed by peroxidases is growing, because they can be
considered a valid alternative to chemical catalysis [5, 6, 12,
17]. Besides hydrolytic enzymes, oxidative enzymes represent
a significant portion of these catalysts; in particular, fungal
and plant oxidative enzymes are often used, while bacterial
oxidative enzymes are still quite rare. However, enzymes
from bacteria are easier to prepare because they are easily
cultivated and many efficient procedures for their genetic
manipulation have become standard in biomolecular studies.
Consequently, the possibility of substituting enzymes of
other origins with microbial alternatives is of great interest.
Oxidativemetal enzymes are widespread in bacteria. An issue
in enzyme-mediated oxidative polymerizations is the number
and variety of accepted substrates. Often, simple substrates
(e.g., phenols) are easily transformed, while more complex
ones (e.g., polyphenols) cannot be used.
E. coli HPI is a potential oxidative biocatalyst because it
has both catalase and peroxidase activity [31, 32]. HPI is a
metal based enzyme, containing Fe(II) in its catalytic site and
its activity is connected to the oxidation state changes of iron.
In the case of HPI it is also known that its catalase activity
takes place at the iron site. Hydrogen peroxide is a small
molecule that can easily penetrate the enzyme reaching the
metal site. The issue becomes more complex when consid-
ering molecules of bigger size (as epicatechin) and growing
polymers. In this paper, a recombinant HPI enzyme from E.
coliwas used in two different forms: the enzyme immobilized
on the IMAC resin and the purified enzyme. All the prepara-
tions are active in test oxidative experiments, showing negli-
gible differences. In contrast, the activity retention is different
depending on the preparation. The enzyme immobilized on
the resin is still fully active after two months, when it is
conserved at 4∘C.The free enzyme fast loses its activity at both
4∘C and −20∘C. This different behaviour can be explained
considering the enzyme specific form. When it is blocked on
the resin the enzyme resides inside the polymeric support; as
a consequence, its 3D structure is stabilized and the activity
BioMed Research International 7
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Figure 3: Oligomers effects on A375 (a and b) and WM266-4 (c and d) proliferation. Cells were treated with increasing concentrations
(0.1–10 𝜇g/ml) of polymers A and B or EC for 3 (a and c) and 6 days (b and d). Cell proliferation was analysed by 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay and results were expressed as mean of percentage of the number of cells with respect to
control cells. Data are shown as mean ± SEM. ∗𝑝 < 0.05.
is maintained for long time. Here, the temperature is less
important. When in the free form, the enzyme is subjected
to the solvent effect without any stabilization; thus, it tends
to lose its native conformation showing an overall loss of
activity. In conclusion, the enzymatic resin is both active and
stable; in addition, it can be used several times.
In a previous work HPI was used in polymerization
reactions of some aromatic substrates [16]. Results confirmed
that the enzyme can act as a catalyst in oxidative polymer-
izations. Depending on the substrate the prepared oligomers
had a specific length; however, the use of polyphenols as
substrate was still to be tested. In addition, from the literature
it is known that HRP can be used to prepare oligomers of
catechins that can be interesting for their biological activity
[4]. Everything considered, it is interesting to test the use
of HPI for the preparation of (−)-epicatechin oligomers.
8 BioMed Research International
G0/G1
S
G2
∗ ∗
EPI POl A POL BCTRl
Cell treatment
0
50
100
150
C
ell
s (
%
)
(a)
G0/G1
S
G2
∗ ∗
0
20
40
60
80
100
120
C
ell
s (
%
)
EPI POL A POL BCTRL
Cell treatment
(b)
Figure 4: Oligomers effects on A375 (a) and WM266-4 (b) cell cycle. Cells were treated (10 𝜇g/ml) with polymers A and B or EC for 6 days
and cell cycle was analysed by fluorescence-activated cell sorter (FACS). Results are expressed as percentage of the cell population in each
phase. Data are shown as mean ± SEM (standard error of mean). ∗𝑝 < 0.05.
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Figure 5: Oligomers effects on A375 (a) and WM266-4 (b) viability. Cells were treated with polymers A and B or EC (10 𝜇g/ml) for 6
days and cell death was analysed by fluorescence-activated cell sorter (FACS). Results are expressed as percentage of apoptotic and late
apoptotic/necrotic cells in all samples. Data are shown as mean ± SEM. ∗𝑝 < 0.05. CAM− identifies apoptotic cells (Calcein-AMlow) and
CAM− PI+ identifies late apoptotic/necrotic cells (Calcein-AMlow, propidium iodide treated).
Experiments with different combinations of conditions to
obtain different epicatechin polymers were performed, and
this was also done using HRP, to have a comparison. Results
demonstrated that reactions performed with HRP or HPI
completely consumed the substrate in line with literature
data [4]. However, the oligomer length depends on several
factors; the most important ones are the number of the
started polymerization chains and their lifetime. Decreasing
the substrate/enzyme ratio a smaller number of chains are
activated and if their lifetime is long enough, the produced
oligomer is longer. In contrast, because the polymerization
is sustained by the oxidation state of the catalyst, decreasing
the H2O2 concentration decreases the lifetime of the chain
that therefore gives shorter oligomers (compare products of
experiments P2 and P6) (Tables 4 and 5). The availability of
the H2O2 is influenced by the competition of the two HPI
activities: the catalase and the peroxidase ones. Finally, the
insoluble product obtained in one experiment lost part of
one epicatechin unit. This can be related to the mechanism
of chain termination that can derive from a hydrogen loss or
gain, or from a molecule part loss. When using the enzyme
resin the product resembles that of the insoluble product
BioMed Research International 9
from HRP; this seems to confirm that the chain termination
is different in solution or in solid phase.
In conclusion of this part, it is possible to state that HPI
in the immobilized form can be used to catalyze polyphenol
polymerization; that it is a stable catalyst; and that it can be
used several times without losing its activity. In comparison
to HRP, obtained products are similar and HPI can be
considered a valuable alternative.
The last part of the present study concerns the biological
activity of the prepared oligomers.
The biological tests have been performed on two samples
(one from HRP and one from HPI, called polymers A and B,
resp.) chosen because they have the same length. Oligomer
samples used in this study were purified before testing and
their biological activity was investigated on the proliferation
cell cycle. In both utilized cell lines, exposure to oligomers
induced a reduction in tumor cell proliferation.The reduction
in cell proliferation was primarily due to an arrest of the
cell cycle in G0/G1 phase with a concurrent reduction in S
phase. As shown by viability evaluation as a result of cell
cycle arrest some cells undergo apoptosis.The ability of many
catechins to inhibit tumor cell proliferation or exert cytotox-
icity is well documented in many in vitro tumor models. As
reported in literature catechins can differently affect tumor
cell lines depending on their structure and on dose and time
of treatment and type of intracellular trafficking in the cells
[27, 33]. However, some authors suggest that also the degree
of polymerization can affect catechin efficacy; in fact, Pierini
et al. [34] showed that nongalloylated flavan-3-ols apple-
derived monomer and dimers do not affect tumor cells pro-
liferation and viability, while the oligomers and polymers are
effective. Agarwal et al. [35] observed a correlation between
the degree of polymerization and the antiproliferative activity
on prostate cancer cell lines. We have not observed any effect
on cell proliferation, viability, and cell cycle with epicatechin
in our tumor models differently with respect to what was
reported in literature on catechin as EGCG effects on human
fibrosarcoma cells [33]. These results could depend on the
tumor cell line selected; in fact literature analysis reveals that
the epicatechin effects are dependent on selected tumor cells
[2, 3]; another explanation could be the low concentrations
utilized when compared with that which was shown to be
active in other models [23, 30].
The overall results are consistent with others reported in
the literature [4] where the same kinds of oligomers with a
similar biological activity were obtained. The novelty of this
work is that an alternative enzyme as HPI versus HRP can be
used to prepare oligomers (A and B). Moreover, in this paper
we demonstrated that the oligomeric forms of epicatechin are
more effective than its monomer in the reduction of tumoral
cell proliferation and that the reduction in cell proliferation
was primarily due to an arrest of the cell cycle in G0/G1 phase
with a concurrent reduction in S phase.
5. Conclusions
In conclusion, HPI enzyme can be considered a valuable
alternative to vegetal derived enzymes in the preparation of
(−)-epicatechin oligomers with a biological activity against
tumor proliferation. Even ifmuchwork is still to be done,HPI
can represent a good biocatalyst and epicatechin oligomers
merit some attention as antitumoral agents.
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